Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Vagifem Low Dose for Postmenopausal Atrophic Vaginitis Symptoms

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Novo Nordisk A/S
ClinicalTrials.gov Identifier:
NCT00108849
First received: April 19, 2005
Last updated: May 12, 2016
Last verified: May 2016